Life sciences and health care investment banking

Who we are

Deloitte Corporate Finance LLC (DCF) is an active investment banking advisor to middle-market companies in the life sciences and health care industry globally. Our team combines decades of transaction execution experience with a sector-focused approach, offering deep domain knowledge and industry connectivity. We maintain regular dialogue with both strategic players and financial sponsors (private equity investors) and provide up-to-date market capital markets and M&A insights to our clients. Working in conjunction with the Deloitte Touche Tohmatsu Limited network of member firms, DCF delivers broad and integrated domestic and international execution capabilities across sell-side, buy-side, divestiture, and capital raise mandates; as well as related finance and accounting, tax, operational, human capital, and IT services necessary to execute complex transactions.

Our experience

Our team has advised on transaction processes across a wide variety of life sciences and health care industry sectors. These deals included primary and secondary buyouts, strategic sales, advisory services, and private financing transactions.

Over the last three years, Deloitte’s life sciences and health care investment banking advisors have completed many transactions globally, including strategic sales, majority and minority private equity recapitalizations, private debt capital raises, and buy-side advisory services.

Industry sub-sectors

• Health care services, including multi-unit providers and physician practice management companies, home health, pharmacy, hospitals, and clinics
• Health care technology and tech-enabled services
• Life sciences and pharma services, including pharmaceutical manufacturing, contract research organizations, contract development, and manufacturing organizations, laboratories, health and regulatory affairs, and commercialization services
• Medical devices, supplies, and distribution
• Payor and employer health care services, including managed care organizations, third-party administrators, pharmacy benefit managers, and corporate wellness services

How we can help

By being client-focused: Leveraging deep sector knowledge and transaction experience, DCF offers a tailored, client-focused approach to M&A. Our professionals appreciate that every client and business is unique. We work closely with our clients (corporations and founders) to understand their goals and structure a transaction process focused on those objectives.

By aligning value drivers with the vision: Our team provides strategic, hands-on guidance throughout each stage of the process—from evaluating strategic alternatives to closing. Through years of experience, we have developed critical insights into value drivers, investor concerns and mitigants, and transaction management strategies. DCF’s model combines M&A experience with access to a global network of resources to help clients navigate the transaction process.

By communicating and collaborating: We continue to cultivate strong relationships with key strategic players and private equity groups in the life sciences and health care sector. Continual and transparent dialogue with major stakeholders has resulted in effective outcomes and real-time insights, which help our clients navigate a rapidly changing environment.

By being flexible and agile: By tailoring processes to changing market conditions, we’ve pivoted to innovative tactics so our clients can tell their stories effectively to priority buyers and investors. It is our belief that smart preparation and clean execution help enable efficient processes for our clients and engage eager buyers.

Stay informed

To keep you informed of trends, our quarterly industry updates provide an overview of key marketplace trends and M&A transactions, including industry analysis and a reference list of publicly traded companies.

Check out some of our latest insights to stay ahead of what’s next:

Read our most recent quarterly update.